Intracardiac myxoma in the left ventricle: A case report with literature review

LAMGHARI, YOUSSEF and OUZZAOUIT, SARRA and LAKLALECH, SAMIA and DJIBRIL, AHMED and OUKERRAJ, LATIFA and CHERTI, MOHAMED and SAADOUNI, YOUSSEF and BOUHDADI, HANAE and LAAROUSSI, MOHAMED (2025) Intracardiac myxoma in the left ventricle: A case report with literature review. International Journal of Science and Research Archive, 15 (1). pp. 697-702. ISSN 2582-8185

The incidence of intra cardiac masses is low. They are primarily benign cardiac tumors, primary or secondary malignant tumors, or thrombi [1-2]. Seventy-five percent of primary tumors are benign, and more than half of these tumors are myxomas [3]. Cardiac masses can be symptomatic, discovered incidentally, or found at autopsy. Depending on the size and location of the tumor, the clinical presentation may manifest as non-specific heart failure symptoms, including dyspnea, fatigue, or orthopnea. They can also be revealed by thromboembolic complications such as strokes [4]. Echocardiography is useful for distinguishing the type of cardiac mass and its location. It is complemented by CT scans, MRI, and trans esophageal echocardiography, which help specify its location, characteristics, and appearance (echogenicity, mobility, calcification, etc.) and complete the staging workup. Surgical resection is the treatment of choice for cardiac myxomas, and anticoagulation is generally recommended for the initial treatment of intra cardiac thrombi [4, 5], not to mention the histo pathological study that helps determine the nature of the mass.